Skip to content

ADMA Biologics ADMA Interest Paid

Interest Paid at other companies

AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$20.83M+15.1%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$22.4M+0.9%
Biohaven logo
BiohavenBHVN
$54K+72.8%
AbbVie logo
AbbVieABBV
$750.5M+6.8%
TG Therapeutics logo
TG TherapeuticsTGTX
$2.39M-61.2%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$3.58M+51.0%

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's interest paid?
ADMA Biologics (ADMA) reported interest paid of $1.33M in Q1 2026.
How has ADMA Biologics's interest paid changed year-over-year?
ADMA Biologics's interest paid decreased by 51.8% year-over-year, from $2.75M to $1.33M.
What is the long-term trend for ADMA Biologics's interest paid?
Over 2 years (2023 to 2025), ADMA Biologics's interest paid has grown at a -29.1% compound annual growth rate (CAGR), from $18.05M to $9.08M.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.